There’s a price war over weight-loss drugs as Wegovy cuts costs for monthly subscribers

March 5, 2025

https://images.mktw.net/im-66737327

Published: March 5, 2025 at 9:00 a.m. ET

Novo Nordisk said game on, as the Denmark-based drugmaker lowered prices on its obesity treatment Wegovy for those without insurance, and said it would deliver the drug to their homes.

The company’s

NVO move comes a week after Eli Lilly & Co. LLY cut prices for its rival weight-loss drug Zepbound.

This post was originally published on Market Watch

Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks

One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Watch now…